Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : CUE save search
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: -4.9%
H: 1.03%
C: -2.06%
business year cue financial results
Cue Biopharma to Host Business Update Call and Webcast
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 1.9%
H: 3.72%
C: -3.19%
business cue update
Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
Published: 2024-02-29 (Crawled : 15:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.47%
H: 1.41%
C: -2.58%
cue-101 symposium cue
Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: -1.68%
H: 8.87%
C: 7.26%
conference life cue update biopharma sciences
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
Published: 2023-11-22 (Crawled : 13:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.42%
H: 1.67%
C: 0.0%
cue biopharma
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
Published: 2023-11-07 (Crawled : 13:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.0%
H: 3.79%
C: 0.0%
cue biopharma
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 1.35%
H: 16.44%
C: 8.89%
cue-101 positive cue cancer biopharma tumor cue-102 trials
Cue Biopharma to Host Business Update Call and Webcast
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 1.49%
H: 8.78%
C: 8.29%
business cue update
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Published: 2023-09-27 (Crawled : 13:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.42%
H: 8.02%
C: 2.95%
cue biopharma immunotherapy meeting
Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: -1.35%
H: 13.18%
C: 7.27%
cue-101 keytruda cue biopharma study
Manager – Clinical Research & Analytics
Published: 2023-08-25 (Crawled : 18:00) - cuebiopharma.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -3.79%
analytics research
Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 3.04%
H: 0.0%
C: -15.82%
business cue financial results
Cue Biopharma to Host Business Update Call and Webcast - August 2, 2023
Published: 2023-08-02 (Crawled : 16:00) - biospace.com/
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: -5.19%
business cue update biopharma
Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting
Published: 2023-06-14 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.0%
H: 1.76%
C: -5.03%
cue biopharma immunology meeting
Cue Biopharma to Host Investor Call
Published: 2023-06-07 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 1.06%
H: 2.88%
C: -2.62%
cue biopharma
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference
Published: 2023-06-05 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 0.24%
H: 3.16%
C: -3.64%
conference cue biopharma global
Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-05-25 (Crawled : 21:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 1.27%
H: 1.25%
C: -2.25%
cue-101 positive cue update cell biopharma ongoing trials meeting
Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-05-15 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 2.09%
H: 6.15%
C: 1.37%
cue biopharma meeting
Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 2.47%
H: 3.02%
C: -4.83%
business cue financial results
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
Published: 2023-05-08 (Crawled : 12:00) - globenewswire.com
CUE | $1.58 -3.07% -1.87% 170K
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: -2.58%
conference life cue biopharma sciences
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.